Pharmaceuticals & Drug Delivery
PEGylated liposomes, polymeric micelles, and nanogels are at the forefront of targeted drug delivery, enabling precise delivery of anticancer drugs to tumor sites, reducing systemic toxicity, and enhancing therapeutic efficacy. This is a key area for "PEG in pharmaceuticals" and the development of next-generation therapeutics. PEGylation is also a well-established strategy to extend the half-life and improve the stability of protein and peptide drugs, such as interferon and growth hormones, leading to reduced dosing frequency and improved patient quality of life. PEGs are being actively explored as components in novel vaccine formulations to enhance immunogenicity, improve vaccine stability, and facilitate controlled antigen release for more potent and long-lasting immune responses.